Alison Smith

MD, Emory University, 2017-2022
MSc, Emory University, 2020-2022
Post-bachelor Research Fellow, University of Washington IHME, 2015-2017
BA in Biology, Williams College, 2011-2015

Interested in the intersection of clinical infectious diseases and public health, tuberculosis, hospital epidemiology and infection control, and clinical reasoning in medical education.

Current Appointments & Affiliations

House Staff Medicine, Clinical Science Departments

Recent Publications

Beyond Infection: Mortality and End-of-Life Care Associated With Infectious Disease Consultation in an Academic Health System.

Journal Article Clin Infect Dis · October 15, 2024 BACKGROUND: Infectious diseases (ID) physicians are increasingly faced with the challenge of caring for patients with terminal illnesses or incurable infections. METHODS: This was a retrospective cohort of all patients with an ID consult within an academic ... Full text Link to item Cite

Time to Positive Blood Cultures among Critically Ill Children Admitted to the PICU

Journal Article Critical Care Explorations · July 5, 2024 OBJECTIVES: Our study aimed to assess the time to positivity (TTP) of clinically significant blood cultures in critically ill children admitted to the PICU. DESIGN: Retrospective review of positive blood cultures in patients admitted or transferred to the ... Full text Cite

Clinical outcomes in patients with piperacillin/tazobactam-non-susceptible but ceftriaxone-susceptible E. coli or K. pneumoniae bloodstream infection.

Journal Article J Antimicrob Chemother · June 3, 2024 BACKGROUND: A small proportion of Escherichia coli and Klebsiella pneumoniae demonstrate in vitro non-susceptibility to piperacillin/tazobactam but retain susceptibility to ceftriaxone. Uncertainty remains regarding how best to treat these isolates. OBJECT ... Full text Link to item Cite

View All Publications